MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
99 100 Next >
News headline image
Eli Lilly Just Launched Its $149 Obesity Pill ↗
Via Benzinga
Tickers LLY
Exposures Product Safety
News headline image
FDA Review Looms As Replimune Faces Weak Technical Setup ↗
Via Benzinga
Exposures Product Safety
News headline image
Invivyd Stock Surges As FDA Alignment Boosts COVID-19 Program ↗
Via Benzinga
Exposures COVID-19 Product Safety
News headline image
ImmunityBio (IBRX): From R&D Speculation to Record Commercial Revenue
Via Finterra
Topics Economy World Trade
Tickers IBRX JNJ MRK
Exposures Product Safety Supply Chain Tariff
News headline image
CORT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
CORT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
3 Stocks to Buy Now for a Lifetime of Passive Income -- Starting Immediately ↗
Via The Motley Fool
Topics Product Recall
Tickers EPD O PG
Exposures COVID-19 Fossil Fuels Legal
News headline image
Kaplan Fox Encourages Investors of ImmunityBio, Inc. (NASDAQ: IBRX) to Contact the Firm Before Lead Plaintiff Deadline on May 26, 2026
Via NewMediaWire
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Encourages Investors of ImmunityBio, Inc. (NASDAQ: IBRX) to Contact the Firm Before Lead Plaintiff Deadline on May 26, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
Via Benzinga
Tickers JNJ
Exposures Product Safety
News headline image
The "Daily Pill" Revolution: Eli Lilly’s Orforglipron Shatters Records with 25% Weight Loss
Via MarketMinute
Tickers AMGN LLY NVO PFE
Exposures Product Safety
News headline image
CORT INVESTOR ALERT: Investors of Corcept Therapeutics, Inc. (NASDAQ: CORT) Are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
CORT INVESTOR ALERT: Investors of Corcept Therapeutics, Inc. (NASDAQ: CORT) Are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Alerts Investors of ImmunityBio, Inc. (IBRX) to a Securities Class Action Deadline on May 26, 2026
Via NewMediaWire
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Alerts Investors of ImmunityBio, Inc. (IBRX) to a Securities Class Action Deadline on May 26, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Waters Stock Shoots Higher As FDA Clears At-Home Cervical Cancer Screening Kit ↗
Via Benzinga
Exposures Product Safety
News headline image
How One Former Financial Planner is Reshaping Financial Education for Women across Australia
Via AB Newswire
Topics Credit Cards Product Recall
Exposures Interest Rates Legal Product Safety
News headline image
FormBlends Delivers Personalized Compounded Medication Directly to Users from an FDA-Registered Pharmacy
Via Press Release Distribution Service
Topics Supply Chain
Exposures Product Safety Supply Chain
News headline image
Adia Nutrition Strikes Major Partnership with Leading Atlanta Clinic to Launch Groundbreaking Autism Clinical Study
Via Newsfile
Topics Supply Chain
Tickers ADIA
Exposures Product Safety Supply Chain
News headline image
GM Recalls 271K Chevrolet Malibu Vehicles Over Rearview Camera Issue ↗
Via Benzinga
Topics Product Recall
Tickers GM
Exposures Legal Product Safety
What Commodity Importers Get Wrong About Freight and Storage
Via BusinesNews Wire
Exposures Product Safety
News headline image
Outlook Therapeutics Files FDA Resolution Request After Rejection For Vision Loss Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
Nashville Residential Home Options & Memory Care Placements: Service Update
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
News headline image
Corbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive Edge ↗
Via Benzinga
Exposures Product Safety
News headline image
Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse
Via Finterra
Topics Artificial Intelligence Retirement World Trade
Tickers ABT BSX DHR GEHC HOLX MDT
Exposures Artificial Intelligence Pension Product Safety
News headline image
Pizza, Petrol, and Profits: A Deep Dive into Casey’s General Stores (CASY)
Via Finterra
Topics Credit Cards Earnings Economy
Tickers CASY DPZ JPM TSX:ATD YUM
Exposures Electric Vehicles Financial Fossil Fuels
BioMedNewsBreaks – NanoViricides (NYSE American: NNVC) Files for Rare Pediatric Disease Designation for Measles Drug Candidate
Via Investor Brand Network
Tickers NNVC
Exposures COVID-19 Product Safety
News headline image
Neurocrine Biosciences (NBIX): A New Era in Neuroscience and Endocrinology
Via Finterra
Topics Earnings Economy Intellectual Property
Tickers BLK BMY NBIX TEVA
Exposures COVID-19 Financial Intellectual Property
News headline image
Soleno Therapeutics: A Masterclass in Rare Disease Redemption and the $2.9B Exit
Via Finterra
Topics Economy Intellectual Property
Tickers ACAD HRMY NBIX RYTM SLNO
Exposures COVID-19 Intellectual Property Interest Rates
News headline image
Kaiten-zushi and Capital: The High-Tech Growth Story of Kura Sushi USA
Via Finterra
Topics Artificial Intelligence Economy Initial Public Offering
Tickers CAKE DRI KRUS
Exposures Artificial Intelligence Intellectual Property Product Safety
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story